Michael Kosmin

681 total citations
26 papers, 465 citations indexed

About

Michael Kosmin is a scholar working on Genetics, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Kosmin has authored 26 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 9 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Kosmin's work include Glioma Diagnosis and Treatment (9 papers), MRI in cancer diagnosis (5 papers) and Meningioma and schwannoma management (5 papers). Michael Kosmin is often cited by papers focused on Glioma Diagnosis and Treatment (9 papers), MRI in cancer diagnosis (5 papers) and Meningioma and schwannoma management (5 papers). Michael Kosmin collaborates with scholars based in United Kingdom, United States and China. Michael Kosmin's co-authors include Mohamed Elshaer, Ahmed Z. Al-Bahrani, Gianpiero Gravante, Amjid Riaz, Jacob Lawrence, Andrew McQuillin, Khalid Choudhury, Vinita Puri, Hugh Gurling and David Curtis and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Radiology.

In The Last Decade

Michael Kosmin

25 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Kosmin United Kingdom 8 155 88 86 81 73 26 465
Pavlos Vassilakos Greece 19 99 0.6× 130 1.5× 87 1.0× 109 1.3× 5 0.1× 48 774
Bart Frizzell United States 11 53 0.3× 200 2.3× 104 1.2× 76 0.9× 37 0.5× 41 402
Puy Garrastachu Spain 10 168 1.1× 125 1.4× 39 0.5× 63 0.8× 22 0.3× 22 499
Christopher A. Sarkiss United States 14 53 0.3× 69 0.8× 30 0.3× 159 2.0× 21 0.3× 26 503
Mitsugu Omasa Japan 17 70 0.5× 400 4.5× 97 1.1× 278 3.4× 37 0.5× 66 822
M. Nathan Nair United States 13 23 0.1× 56 0.6× 42 0.5× 148 1.8× 17 0.2× 38 545
Kamal Sahni India 11 158 1.0× 60 0.7× 36 0.4× 173 2.1× 6 0.1× 40 375
Niclas Pettersson Sweden 16 285 1.8× 391 4.4× 137 1.6× 160 2.0× 287 3.9× 48 761
Rui Sun China 15 20 0.1× 140 1.6× 151 1.8× 227 2.8× 8 0.1× 66 554

Countries citing papers authored by Michael Kosmin

Since Specialization
Citations

This map shows the geographic impact of Michael Kosmin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kosmin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kosmin more than expected).

Fields of papers citing papers by Michael Kosmin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kosmin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kosmin. The network helps show where Michael Kosmin may publish in the future.

Co-authorship network of co-authors of Michael Kosmin

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kosmin. A scholar is included among the top collaborators of Michael Kosmin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kosmin. Michael Kosmin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Penn, Jack, Richard Dobson, Naomi Fersht, et al.. (2025). Utilising Natural Language Processing to Identify Brain Tumor Patients for Clinical Trials: Development and Initial Evaluation. World Neurosurgery. 197. 123907–123907. 1 indexed citations
2.
Anjari, Mustafa, Sebastian Brandner, Naomi Fersht, et al.. (2024). Isocitrate Dehydrogenase 1/2 Wildtype Adult Astrocytoma with WHO Grade 2/3 Histological Features: Molecular Re-Classification, Prognostic Factors, Clinical Outcomes. Biomedicines. 12(4). 901–901. 2 indexed citations
3.
Manolopoulos, S., et al.. (2023). The Feasibility of Dose-Escalated Radiation Therapy for Glioblastoma Using Biological Image Guided Adaptive Radiotherapy (BIGART). International Journal of Radiation Oncology*Biology*Physics. 117(2). e83–e83.
4.
Hussein, Ziad, Hani J. Marcus, Joan Grieve, et al.. (2023). Pituitary function at presentation and following therapy in patients with non-functional pituitary macroadenomas: a single centre retrospective cohort study. Endocrine. 82(1). 143–151. 2 indexed citations
5.
Hussein, Ziad, Joan Grieve, Neil Dorward, et al.. (2023). Non-functioning pituitary macroadenoma following surgery: long-term outcomes and development of an optimal follow-up strategy. Frontiers in Surgery. 10. 1129387–1129387. 3 indexed citations
6.
Kosmin, Michael, et al.. (2023). Isotoxic dose escalated radiotherapy for glioblastoma based on diffusion-weighted MRI and tumor control probability—an in-silico study. British Journal of Radiology. 96(1146). 20220384–20220384. 1 indexed citations
7.
Mancini, Laura, et al.. (2022). Is Diffusion Tensor Imaging-Guided Radiotherapy the New State-of-the-Art? A Review of the Current Literature and Technical Insights. Applied Sciences. 12(2). 816–816. 4 indexed citations
8.
Fersht, Naomi, Patrick Grover, Neil Kitchen, et al.. (2022). Integration of a personalised mobile health (mHealth) application into the care of patients with brain tumours: proof-of-concept study (IDEAL stage 1). SHILAP Revista de lepidopterología. 4(1). e000130–e000130. 6 indexed citations
9.
Kosmin, Michael, Anwar R. Padhani, Andrew Gogbashian, et al.. (2020). Comparison of Whole-Body MRI, CT, and Bone Scintigraphy for Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to Bone. Radiology. 297(3). 622–629. 22 indexed citations
10.
Kosmin, Michael & Naomi Fersht. (2020). Radiotherapy for Pituitary Tumors. 2 indexed citations
11.
Kosmin, Michael, Joseph R. Ledsam, Bernardino Romera‐Paredes, et al.. (2019). Rapid advances in auto-segmentation of organs at risk and target volumes in head and neck cancer. Radiotherapy and Oncology. 135. 130–140. 99 indexed citations
12.
Woolf, David, Sonia P. Li, Simone Detre, et al.. (2019). Assessment of the Spatial Heterogeneity of Breast Cancers: Associations Between Computed Tomography and Immunohistochemistry. SHILAP Revista de lepidopterología. 11. 1179299X19851513–1179299X19851513. 4 indexed citations
13.
14.
Kosmin, Michael, Francesca Soldà, Elena Wilson, et al.. (2018). The impact of route of diagnosis on survival in patients with glioblastoma. British Journal of Neurosurgery. 32(6). 628–630. 4 indexed citations
15.
16.
Kosmin, Michael, Andreas Makris, Noorulhuda Jawad, et al.. (2017). Splenic Enlargement and Bone Marrow Hyperplasia in Patients Receiving Trastuzumab-Emtansine for Metastatic Breast Cancer. Targeted Oncology. 12(2). 229–234. 6 indexed citations
17.
Kosmin, Michael, et al.. (2016). Current Views on Clinical Oncology Training from the 2015 Oncology Registrars' Forum Survey. Clinical Oncology. 28(9). e121–e125. 4 indexed citations
18.
Elshaer, Mohamed, Gianpiero Gravante, Michael Kosmin, Amjid Riaz, & Ahmed Z. Al-Bahrani. (2016). A systematic review of the prognostic value of lymph node ratio, number of positive nodes and total nodes examined in pancreatic ductal adenocarcinoma. Annals of The Royal College of Surgeons of England. 99(2). 101–106. 64 indexed citations
19.
Kosmin, Michael, et al.. (2012). Hypertension complicating 131I-meta-iodobenzylguanidine therapy for neuroblastoma. European Journal of Nuclear Medicine and Molecular Imaging. 39(4). 597–601. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pavlos Vassilakos Breakdown of academic impact, for papers by Bart Frizzell Breakdown of academic impact, for papers by Puy Garrastachu Breakdown of academic impact, for papers by Christopher A. Sarkiss Breakdown of academic impact, for papers by Mitsugu Omasa Breakdown of academic impact, for papers by M. Nathan Nair Breakdown of academic impact, for papers by Kamal Sahni Breakdown of academic impact, for papers by Niclas Pettersson Breakdown of academic impact, for papers by Rui Sun
Rankless by CCL
2026